Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)

CompletedOBSERVATIONAL
Enrollment

264

Participants

Timeline

Start Date

November 12, 2015

Primary Completion Date

October 21, 2021

Study Completion Date

October 21, 2021

Conditions
Primary Immunodeficiency Diseases (PID)
Interventions
BIOLOGICAL

HYQVIA

Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase

Trial Locations (30)

10032

Columbia University Medical Center, New York

10461

Montefiore Medical Center, The Bronx

11021

Northwell Health, Inc. PRIME, Great Neck

11501

Winthrop University, Mineola

14830

Corning Center for Clinical Research, Corning

15241

Allergy & Clinical Immunology Associates, Pittsburgh

28203

Carolinas Healthcare System, Charlotte

28277

Allergy Asthma & Immunology Relief of Charlotte, Charlotte

31707

Georgia Pollens Clinical Research Centers, Inc., Albany

43235

Optimed Research, LTD, Columbus

63110

Washington University, St Louis

73120

Allergy, Asthma and Clinical Research Center, Oklahoma City

73131

OK Institute of Allergy & Asthma Clinical Research, LLC, Oklahoma City

74136

Vital Prospects Clinical Research Institute, P.C., Tulsa

75070

McKinney Allergy and Asthma Center, McKinney

75230

Allergy / Immunology Research Center of North Texas, Dallas

77030

Texas Children's Hospital, Houston

80233

IMMUNOe International Research Centers, Thornton

80907

Asthma and Allergy Associates, PC, Colorado Springs

80920

Pikes Peak Allergy and Asthma, Colorado Springs

84132

University of Utah, Salt Lake City

90277

Riviera Allergy Medical Center, Redondo Beach

90404

UCLA School of Medicine, Santa Monica

92697

University of California Irvine Medical Center, Irvine

93301

Kern Allergy Medical Clinic, Bakersfield

95819

Capital Allergy & Respiratory Disease Center, Sacramento

02115

Boston Childrens Hospital, Boston

48187-5097

Canton Health Center, Canton

29420-4211

National Allergy, Asthma & Urticaria Centers of Charleston, PA, North Charleston

78664-5226

Greater Austin Allergy, Asthma, & Immunology, Round Rock

All Listed Sponsors
lead

Baxalta now part of Shire

INDUSTRY

NCT02593188 - Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global) | Biotech Hunter | Biotech Hunter